Literature DB >> 908753

Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

C R Kahn, K Baird, J S Filier, D B Jarrett.   

Abstract

Autoantibodies to the insulin receptor have been detected in the sera of several patients with the Type B syndrome of insulin resistance and acanthosis nigricans. In this study we have used three of these sera (B-1, B-2, and B-3) as probes of the insulin receptor in isolated rat adipocytes. Preincubation of adipocytes with each of the three sera resulted in an inhibition of subsequent [(125)I]insulin binding. 50% inhibition of binding occurred with serum dilutions of 1:5 to 1:7,500. As in our previous studies with other tissues, Scatchard analysis of the insulin-binding data was curvilinear consistent with negative cooperativity. Computer analysis suggested that in each case the inhibition of binding was due to a decrease in receptor affinity rather than a change in available receptor number. In addition to the effects on insulin binding, adipocytes pretreated with antireceptor sera also showed alterations in biological responses. All three sera produced some stimulation of basal glucose oxidation. With serum B-3, maximal stimulation of glucose oxidation occurred at a serum concentration that inhibited binding by only 10-15%, whereas with serum B-2 the dilution curves for inhibition of binding and stimulation of glucose oxidation were superimposable. Serum B-1 behaved as a partial agonist; that is, it inhibited binding more effectively than it stimulated glucose oxidation. Cells pretreated with this serum in a concentration which inhibited binding by 80% also showed a five-fold shift to the right in the dose response of insulin-stimulated glucose oxidation, whereas spermine-stimulated glucose oxidation was unaffected. Serum B-2, which contained the highest titer of antireceptor antibodies, also stimulated 2-deoxy-glucose transport, as well as glucose incorporation into lipid and glycogen. Both the ability of the serum to inhibit binding and stimulate glucose utilization were enriched in purified immunoglobulin fractions and retained in the F(ab')(2) fragment of the IgG. In addition, the bioactivity was blocked by antihuman IgG but not by anti-insulin antibodies. Enzymatic digestion of adipocytes with trypsin resulted in a complete loss of insulin-stimulated bioactivity of serum B-3, but had only minor effects on the glucose oxidation produced by serum B-1 or B-2.These data suggest that the antibodies present in these three sera bind to different determinants on the insulin receptor. Thus, these antibodies may be useful probes of receptor structure and function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908753      PMCID: PMC372462          DOI: 10.1172/JCI108861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.

Authors:  M RODBELL
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

2.  ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

Authors:  J P KRISS; V PLESHAKOV; J R CHIEN
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

3.  Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

4.  Insulin-induced dissociation of its receptor into subunits: possible molecular concomitant of negative cooperativity.

Authors:  B H Ginsberg; C R Kahn; J Roth; P De Meyts
Journal:  Biochem Biophys Res Commun       Date:  1976-12-20       Impact factor: 3.575

5.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

6.  Insulin-resistant diabetes associated with increased endogenous plasma insulin followed by complete remission.

Authors:  J B FIELD; P JOHNSON; B HERRING
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

7.  Activation of rat adipocyte glycogen synthase by insulins.

Authors:  J C Lawrence; J J Guinovart; J Larner
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

8.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Receptors for peptide hormones. New insights into the pathophysiology of disease states in man.

Authors:  C R Kahn; K Megyesi; R S Bar; R C Eastman; J S Flier
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

10.  Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor.

Authors:  D B Jarrett; J Roth; C R Kahn; J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more
  45 in total

1.  Autoantibodies to the insulin receptor activate glycogen synthase in rat adipocytes.

Authors:  J C Lawrence; J Larner; C R Kahn; J Roth
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

Review 2.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity.

Authors:  R Herrera; L Petruzzelli; N Thomas; H N Bramson; E T Kaiser; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor.

Authors:  M A Soos; K Siddle; M D Baron; J M Heward; J P Luzio; J Bellatin; E S Lennox
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

5.  Systemic lupus erythematosus presenting as hypoglycemia with insulin receptor antibodies.

Authors:  R L Howard; L K Beck; A Schneebaum
Journal:  West J Med       Date:  1989-09

6.  Insulin-like effects of dithiothreitol on isolated rat adipocytes.

Authors:  H Goko; S Takashima; A Kawamuro; A Matsuoka
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

7.  Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes.

Authors:  C Plas; B Desbuquois
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

8.  Insulin-stimulated protein phosphorylation in 3T3-L1 preadipocytes.

Authors:  C J Smith; P J Wejksnora; J R Warner; C S Rubin; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Lateral diffusion of surface immunoglobulin, Thy-1 antigen, and a lipid probe in lymphocyte plasma membranes.

Authors:  P Dragsten; P Henkart; R Blumenthal; J Weinstein; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta.

Authors:  L M Petruzzelli; S Ganguly; C J Smith; M H Cobb; C S Rubin; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.